Penn study seeks best way to warn patients about deadly chemo risk
NCT ID NCT06559462
Summary
This study aimed to find the best ways to encourage doctors and patients to use a genetic test before starting certain chemotherapy drugs. The test checks for a gene change that can cause severe, sometimes fatal, side effects. Researchers gathered feedback from doctors, patients, and caregivers on different messages and educational materials to see which ones were most effective at promoting the test.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.